Researchers present advance in re-treatment with CAR T therapy

Researchers from the University of Pennsylvania's Abramson Cancer Center presented preliminary results of an ongoing Phase I clinical trial demonstrating successful re-treatment with CAR T cell therapy for patients whose cancers relapsed after previous CAR T therapy at the 2022 American Society of Hematology (ASH) Annual Meeting.

source https://medicalxpress.com/news/2022-12-advance-re-treatment-car-therapy.html